Clinical trials
Hematologic Diseases trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| Beijing Boren Hospital | 1 |
| Guangzhou First People's Hospital | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Peking University People's Hospital | 1 |
| Ruijin Hospital | 1 |
| Shanghai BDgene Co., Ltd. | 1 |
| The General Hospital of Western Theater Command | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 9 |
| Anemia | 2 |
| Coronary Artery Disease | 2 |
| Hemorrhagic Stroke | 2 |
| Hemostatic Disorders | 2 |
| Ischemic Stroke | 2 |
| Renal Insufficiency | 2 |
| Thrombocytopenia | 2 |
| COVID-19 | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.